Quark Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Quark Pharmaceuticals's estimated annual revenue is currently $19.1M per year. 0
- Quark Pharmaceuticals's total funding is $61.4M.
Employee Data
- 00
Quark Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | SVP Strategy/Planning | Reveal Email/Phone |
3 | SVP | Reveal Email/Phone |
4 | eVP Regulatory Affairs | Reveal Email/Phone |
5 | VP, Medical Innovation | Reveal Email/Phone |
6 | svp Corporate Development and Investor Relations | Reveal Email/Phone |
7 | SVP Quality Assurance | Reveal Email/Phone |
8 | Chief Scientific Officer | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Senior Director Clinical Research and Biostatistics, Statistics Unit | Reveal Email/Phone |
Quark Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Quark Pharmaceuticals?
Quark Biotech, Inc. is a U.S. based biopharmaceutical company, focused on the development of drugs for unmet medical needs. Based on the proprietary targets identified using our enabling foundation technology, BiFAR, we are developing antibodies, siRNA based therapeutics and small molecules potentially applicable to several diseases. Our most advanced product, the small molecule BT16, is in clinical phase II for dyslipidemia.
keywords:N/A$61.4M
Total Funding
N/A
Number of Employees
$19.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Quark Pharmaceuticals News
... ICo Therapeutics, Quark Pharmaceuticals, Rexhan Pharmaceuticals ... Glaxo Smith Kline, Sanofi Aventis / Genzyme, Isis Pharmaceuticals/ Ionis...
Quark Pharmaceuticals Inc., Baxter International Inc., B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., AM-Pharma B.V.,...
Quark Pharmaceuticals; Alloksys; Angio Biomedica Corporation; Stealth Bio Therapeutics; Silver Creek Pharmaceuticals; Am Pharma Holding; Ischemix; Biomerieux...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.5M | 0 | N/A | N/A |
#2 | $65M | 0 | N/A | N/A |
#3 | $1M | 0 | N/A | $33.4M |
#4 | $11.3M | 0 | N/A | $12M |
#5 | $0.1M | 1 | 0% | N/A |